Author Archives: Scalper1

Analyst Coverage Starts On Global Blood, Post IPO

Several analysts initiated coverage on Global Blood Therapeutics (GBT), which rates among the top five IPOs this year after popping more than 100% on its first day of trading and touched a new high of 57 in early trading Tuesday. Morgan Stanley initiated coverage with an overweight rating and a price target of 67. Analyst Mathew Harrison, in the research report, said Global Blood Therapeutics offers “a potentially transformative sickle cell

Sorry Verizon, Google, Facebook Are The Mobile Kings

Search leader Google (GOOGL) and social media king Facebook (FB)also rule supreme in U.S. mobile ad revenue share, according to the latest research report from eMarketer. The two tech firms’ mobile dominance will prove a challenge to newcomer AOL, the Internet company whose parent, Verizon Communications (VZ), announced last week that it will acquire Millennial Media, a Baltimore-based mobile advertising company. The Verizon-Millennial union comes